mRNA

The acquisition expands Curevac's capacity and expertise to further expand its oncology strategy for new therapies that enable patients' immune systems to fight cancer.

Curevac is acquiring privately held Frame Cancer Therapeutics, which focuses on advanced genomics and bioinformatics to identify both unique and common neoantigens for various cancers. "Embedding Frame's technology and expertise into Curevac's oncology research complements our ability to identify and validate promising...

Evonik is investing 220 million dollar in the Tippecanoe site

Evonik is building a new, highly flexible world-scale production facility for pharmaceutical lipids in the USA. The new facility at Evonik's Tippecanoe site in Lafayette, Indiana, will broadly position the company for future growth in new type mRNA-based therapies beyond Covid-19 vaccines. Construction will begin in...